Hinge Health Stock
Hinge Health, Inc.
Company data
- Sector
- Healthcare
- Industry
- Medical - Healthcare Information Services
- Country
- United States
- CEO
- Daniel A. Perez
- Employees
- 1,437
- Market cap
- $8 B
- IPO
- 22/05/2025
Hinge Health, Inc. is headquartered in San Francisco, USA, and operates within the Healthcare sector. The company belongs to the Medical - Healthcare Information Services industry. Established in 2012, the firm creates specialized healthcare software solutions for musculoskeletal and joint health. Their advanced…
Company description based on the data provider's company data, AI-assisted, created on 16/10/2026. Not investment advice.
Hinge Health stock: price history
1D
-5.5%
1W
-3.6%
1M
+5.8%
6M
+128.9%
YTD
+113.5%
1Y
+95.4%
2Y
–
5Y
–
10Y
–
Next earnings date
Next earnings date
02/11/2026 (in 16 days)
Volatility around earnings
~92% stronger price swings than usual
Hinge Health stock scores
- Valuation
Visible after free registration
- Trend
Visible after free registration
- Quality
Visible after free registration
- Dividend
Visible after free registration
- Growth
Visible after free registration
- Insider
Visible after free registration
- Earnings
Visible after free registration
- Revisions
Visible after free registration
- Sentiment
Visible after free registration
- Short Pressure
Visible after free registration
Register for free
Unlock all 11 scores
- 5 credits free on registration
- Access to virtual portfolios and watchlist
- No credit card, no payment details needed
- No subscription, no minimum term
- Our own servers in Germany, no US cloud
Deterministically calculated from financial metrics, not investment advice. Updated nightly, last on 16/10/2026.
Business model & megatrends
Robust business model that benefits noticeably from at least one megatrend.
1 more assignment (Enabler/Second row) Pro-only.
Hinge Health, Inc. has established itself as a provider of specialized software solutions for musculoskeletal health. The platform enables comprehensive management of various medical needs, such as acute injuries, chronic pain, and post-surgical rehabilitation. In addition to clinically oriented applications, the company also offers administrative and operational support to optimize healthcare processes.
- Revenue model
- Transactional
- Recurring revenue
- High
- Pricing power
- Moderate
- Moat
- Narrow
- Moat type
- Switching costs
- Capital intensity
- Low
- Customer concentration
- Unknown
Ask the agents about Hinge Health
Analyst assessment of Hinge Health
PRICE TARGET LOW
US$76.00
CONSENSUS
US$102.77
MEDIAN
US$105.00
PRICE TARGET HIGH
US$140.00
0
STRONG BUY
15
BUY
1
HOLD
0
SELL
0
STRONG SELL
16
TOTAL · Buy
As of: 16/10/2026
Hinge Health stock metrics
P/E
73.64
P/B
22.69
EV/EBITDA
74.53
RETURN ON EQUITY
12.7%
NET MARGIN
20.5%
DEBT/EQUITY
0.02
DIVIDEND YIELD
0.0%
AS OF
30/06/2026
Free float & liquidity
FREE FLOAT
94.8%
FLOAT SHARES
76,513,462
AVG. DAILY VOLUME (30D)
1,818,979
Insider transactions (SEC)
Mecklenburg Gabriel M.I.
Budge James
Budge James
Budge James
Budge James
Attention
1 mention today in US forums, about the same as yesterdayPrice since yesterday: -5.5%
Forums (Reddit)
Institutional holders
Smart Money
Register for free
Register now to see which funds are invested
- 5 credits free on registration
- Access to virtual portfolios and watchlist
- No credit card, no payment details needed
- No subscription, no minimum term
- Our own servers in Germany, no US cloud
Comparable stocks
Frequently asked questions about Hinge Health stock
What does Hinge Health do?
Hinge Health, Inc. is a company in the Healthcare sector, Medical - Healthcare Information Services industry, headquartered in United States.
The CEO is Daniel A. Perez, the company employs around 1,437 people.
The IPO was on 22/05/2025; the stock trades on NYSE under the ticker HNGE.
What do analysts say about Hinge Health stock?
16 analysts rate the stock, the consensus is Buy (as of 16/10/2026).
The average price target is US$102.77, ranging from US$76.00 to US$140.00, with a median of US$105.00.
This is an external assessment, not a statement by Market Jury.
When does Hinge Health report next?
The next earnings date is 02/11/2026.
Around past earnings, price swings were roughly 92% stronger than usual.
Does Hinge Health pay a dividend?
No, Hinge Health currently does not pay a dividend.
Which stocks are comparable to Hinge Health?
Comparable stocks include HealthEquity, Heartflow, Omada Health, Teladoc Health, Evolent Health, SOPHiA GENETICS and Optima Health.
How can I get Hinge Health stock analyzed?
Clicking "Analyze stock" lets five strategies assess Hinge Health against fixed, published rules and judge it bullish, neutral or bearish. The jury states where it disagrees. A free account starts with 5 credits, a quick check costs 1 credit, a full analysis 2 credits.
Not investment advice. Past performance is not an indicator of future results.